In 2013, Apple made headlines with its acquisition of PrimeSense, a leading company in 3D sensors, for approximately $400 million. PrimeSense had powered Microsoft Kinect for Xbox 360 and contributed to Apple’s groundbreaking Face ID technology. Now, the founders of PrimeSense, Michael Shpigelmacher, Aviad Maizels, and Alex Shpunt, have embarked on a new venture with their medical startup, Bionaut Labs. Instead of sensor technology, their focus is on exploring the intricate depths of the human brain.
Bionaut Labs is currently conducting tests at a Mayo Clinic facility and is preparing to commence clinical trials in collaboration with five esteemed US medical centers, as it seeks FDA approval. To support their groundbreaking work, Bionaut is in the process of raising a Series B-1 funding round, with the OurCrowd investment platform featuring prominently.
Continue reading… “Bionaut Labs: Pioneering Micro-Robots Revolutionize Targeted Brain Treatments”